Refining meta-analyses in advanced biliary tract cancer Wenxin LiXudong ZhuYefu Liu in Hepatology International Article 18 October 2025
The Landscape of Genomic Alterations in Receptor Tyrosine Kinase Pathways in Biliary Cancers: Implications for Targeted Therapies Ioannis A. Voutsadakis in Journal of Gastrointestinal Cancer Article Open access 18 October 2025
Comment on “Hepatic arterial infusion chemotherapy combined with lenvatinib and programmed death receptor-1 inhibitors for hepatocellular carcinoma with Vp4 portal vein tumor thrombus: a multicenter, propensity-score matching comparative study” Yuanbin ChenYuehua Yan in Hepatology International Article 18 October 2025
Robotic Left Hepatectomy with Hilar Dissection and Portal Lymphadenectomy Following Preoperative Gemcitabine, Cisplatin, and Pembrolizumab for Intrahepatic Cholangiocarcinoma Juan Felipe Salazar GonzalezDaniel AlisedaBrendan Christopher Visser in Annals of Surgical Oncology Article 18 October 2025
Insights into surgical conversion for Atez/Bev-treated u-HCC Cong Liu in Hepatology International Article 18 October 2025
Predictive Value of Serum Albumin Levels and Liver Enzymes for Survival in Patients with Pancreatic Cancer Mohammad AlmasiNiloofar FarajiAmineh Hojati in Indian Journal of Surgical Oncology Article 17 October 2025
The association between antiviral therapy and 10-year overall survival of patients undergoing liver resection for hepatitis C virus- or hepatitis B virus-related hepatocellular carcinoma Yi-Hao YenYueh-Wei LiuChih-Yun Lin in Updates in Surgery Article 17 October 2025
The efficacy and safety analysis of D-TACE combined with donafenib and tislelizumab in recurrent hepatocellular carcinoma after surgery Haohao LuBin LiangChuansheng Zheng in Scientific Reports Article Open access 17 October 2025
Novel combination therapy with phenformin enhances the effects of lenvatinib in hepatocellular carcinoma via AMPK-mediated PDGFRβ degradation Duo LiQi ZhongXiaoping Yang in Cancer Cell International Article Open access 17 October 2025
Characterizing and Addressing the Financial, Time, and Administrative Burdens of Cancer and its Care Kendall LinSana KagalwallaArjun Gupta in Current Treatment Options in Oncology Article Open access 17 October 2025
Second-Line Treatment in cholangiocarcinoma - Current State of the Art and Future Perspectives Michał SiwekPaulina ChmielLeszek Kraj in Current Treatment Options in Oncology Article Open access 17 October 2025
Development of novel DALY-based indices for assessing productivity loss and resource allocation for liver cancer in the MENA region Shekoofeh Sadat MomahhedArian BanaeeAbolfazl Zendehdel in Population Health Metrics Article Open access 17 October 2025
Multi-omics profiling reveals downregulated tumor lysine metabolism reshaping the immune microenvironment and therapeutic responses in hepatocellular carcinoma Xinlan LuMin QiangYungang Xu in Journal of Translational Medicine Article Open access 17 October 2025
ASO Author Reflections: Robotic Segmental Hepatic Resection Associated to Pancreatoduodenectomy for Gallbladder Cancer and Extrahepatic Cholangiocarcinoma Guanyu WangZhuzeng Yin in Annals of Surgical Oncology Article 17 October 2025
Clinical significance of preoperative serum VEGF in predicting metachronous liver metastasis of colorectal cancer: development of a novel nomogram Yufei GuJin DuXintao Wang in World Journal of Surgical Oncology Article Open access 17 October 2025
COVID-19, inflammatory cytokines, and digestive system cancers: a bidirectional Mendelian study and mediation analysis Yi LiangWei XiaoQiu Chen in Discover Oncology Article Open access 17 October 2025
Immune cell dynamics and prognostic role of M2 macrophages and LDOC1 in colon adenocarcinoma Laibin LuoZhimin XuRong Huang in Discover Oncology Article Open access 17 October 2025